Henlius Biotech Gets FDA Nod for HLX07 Clinical Study in CSCC
Shanghai Henlius Biotech (HKG: 2696) has announced that it has received approval from the US...
Merck
Merck’s Gabor Outlines AI and Biomedicine Strategy in China
Allan Gabor, president of Merck KGaA China and executive vice president of Merck Electronics, shared...
Nerviano Medical Sciences Collaborates with Merck on PARP1 Inhibitor NMS-293
Italy-based Nerviano Medical Sciences S.r.l. (NMS), which is 90% owned by Chinese investment fund SARI...
Merck KGaA Opens Viral Clearance Lab in Shanghai’s Biologics Testing Center
German pharmaceutical giant Merck KGaA has opened a viral clearance (VC) laboratory as part of...
Biocytogen and Merck KGaA Ink Global Deal for RenMice Platform Licensing
Sino-US contract research organization (CRO) Biocytogen Pharmaceuticals (Beijing) Co., Ltd has entered into a global...
Merck KGaA Launches Uptune Program in Asia, Offers Startups Up to €100,000
Germany-based life sciences giant Merck KGaA has launched the Uptune program in Asia, offering up...
Eucure Biopharma Doses First Patient in YH003 + Keytruda Trial for Mucosal Melanoma
Eucure Biopharma, a subsidiary of Sino-US contract research organization Biocytogen, announced that the first patient...
Organon’s China Head Shi Wang Departs to Lead Sanofi Greater China
Women’s health specialist Organon (NYSE: OGN) announced the departure of its former China unit head...
Merck KGaA’s Erbitux Approved in China for Head and Neck Cancer Treatment
Germany-based pharmaceutical firm Merck KGaA announced that China’s National Medical Products Administration (NMPA) has issued...